Nvidia shares fall and Eli Lilly receives China approval
NVDA NVIDIA Corp
$166.09 -4.40%
View chart & analysis → - 1Nvidia shares fell more than 6% in pre-market trading.
- 2China's drug regulatory authority approved orforglipron.
- 3Eli Lilly shares rose 2.8%.
So what's the key point?
Nvidia shares fell more than 6% in pre-market trading.
Source Investing.com +1 · View original ↗
Nothing hidden: past picks and how they did against the S&P 500.